Huaizhong Health Group, Inc. (ADAD)
USD 0.11
(0.0%)
USD 0.11
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 20.55 Thousand | 40.5 Thousand |
| Cost of Revenue | - | - | - | - | 15.34 Thousand | 33.61 Thousand |
| Gross Profit | - | - | - | - | 5207.00 | 6896.00 |
| Operating Expenses | 29.17 Thousand | 30.82 Thousand | 36 Thousand | 126.09 Thousand | 4634.00 | 8031.00 |
| Selling, General and Administrative Expenses | 29.17 Thousand | 30.82 Thousand | 36 Thousand | 126.09 Thousand | 4634.00 | 8031.00 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 29.17 Thousand | 30.82 Thousand | 36 Thousand | 126.09 Thousand | 19.98 Thousand | 41.64 Thousand |
| Operating Income | -29.17 Thousand | -30.82 Thousand | -36 Thousand | -126.09 Thousand | -1135.00 | -3028.00 |
| Interest Expense | - | - | 479.00 | - | - | - |
| Income Tax Expense | - | -29.83 | 479.00 | 2.47 | -1.00 | -3894.00 |
| Earnings before Tax | -29.17 Thousand | -30.82 Thousand | -36.48 Thousand | -126.09 Thousand | -6368.00 | -1135.00 |
| Net Income | -29.17 Thousand | -30.82 Thousand | -36.95 Thousand | -126.09 Thousand | -6368.00 | -1134.00 |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.41 | -0.02 | -0.01 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.41 | -0.02 | -0.01 |
| Weighted Average Shares Outstanding | 31.51 Million | 31.51 Million | 10.45 Million | 308.94 Thousand | 255.35 Thousand | 127.85 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 31.51 Million | 31.51 Million | 10.45 Million | 308.94 Thousand | 255.35 Thousand | 127.85 Thousand |
| Gross Margin | - | - | - | - | 0.25 | 0.17 |
| EBIT Margin | - | - | - | - | 0.37 | -0.03 |
| Profit Margin | - | - | - | - | -0.31 | -0.03 |
| EBITDA | -29.17 Thousand | -30.82 Thousand | -36 Thousand | -125.57 Thousand | 1099.00 | -78.13 Thousand |
| Earnings Before Tax Margin | - | - | - | - | -0.06 | -0.07 |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | - | 10.55 Thousand | 29.17 Thousand | 7346.00 |
| Selling, General and Administrative Expenses | - | - | - | 10.55 Thousand | - | 7346.00 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | - | - | - | 10.55 Thousand | 29.17 Thousand | 7346.00 |
| Operating Income | - | - | - | -10.55 Thousand | -29.17 Thousand | -7346.00 |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | - | -10.55 | -30.17 | -29.17 Thousand |
| Earnings before Tax | - | - | - | -10.55 Thousand | -29.17 Thousand | -7346.00 |
| Net Income | - | - | - | -10.55 Thousand | -29.17 Thousand | 21.82 Thousand |
| Earnings Per Share Basic | - | - | - | -0.00 | - | 0.00 |
| Earnings Per Share Diluted | - | - | - | -0.00 | - | 0.00 |
| Weighted Average Shares Outstanding | - | - | - | 31.51 Million | 31.51 Million | 31.51 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | - | 31.51 Million | 31.51 Million | 31.51 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | - | - | -10.55 Thousand | - | -7346.00 |
| Earnings Before Tax Margin | - | - | - | - | - | - |
CMO
CHIF
2316
BMTX
NAHD
MEDC